Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, please find enclosed Investors' Presentation on financial results for quarter and period ended December 31, 2018. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, please find enclosed Investors' Presentation on financial results for quarter and period ended December 31, 2018. This is for your information and records please.
Results Analysis: Fortis Healthcare, 8K Miles fall on Q3 performance
Fortis Healthcare fell in share price after the company delivered a weak YoY performance, with declines across the board in revenues, net profit and EBIDT. Operating profit margins fell 25% YoY. Prabhat Dairy also declined after net profits fell by over 32% YoY. 8K Miles also fell after reporting Q3 results that included marginal gains in operating profit margins. FORTIS HEALTHCARE LTD. - 532843 - Outcome of Board Meeting
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. on February 13, 2019, inter-alia, considered and approved: 1. Un-Audited Financial Results and Limited Review Report(s) along with the opinion expressed by the Statutory Auditor of the Company for the quarter and period ended on December 31, 2018; and 2. Appointment of Mr. Vivek Kumar Goyal as Chief Financial Officer of the Company and designating him as one of the Key Managerial Personnel of the Company. The effective date of appointment will be separately informed, which shall be on or before May 1, 2019 Ashutosh Raghuvanshi appointed Fortis Healthcare CEO with effect from March
He replaces Bhavdeep Singh, who had tendered in his resignation as the CEO on November 8 last year citing professional and personal reasons Fortis Healthcare Ltd - 532843 - Intimation Under Regulation 30 (LODR) - Appointment Of Chief Executive Officer (CEO)
In continuation to our Letter Ref No. FHL/SEC/2018-19 on November 8, 2018 and pursuant to compliance of Regulation 30 and Para A of Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that the Board at its meeting held today has approved the appointment of Dr. Ashutosh Raghuvanshi as the Chief Executive Officer of the Company w.e.f. March 18, 2019. He will also be designated as one of the Key Managerial Personnel of the Company. Fortis Healthcare Ltd - 532843 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fortis Healthcare Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Fortis Healthcare Ltd - 532843 - Proceedings And Voting Result As Per The Format Prescribed Under Regulation 44 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the Postal Ballot Notice dated December 31, 2018 wherein the following resolution was proposed to be passed by way of postal ballot as well as through e-voting:- 1. Special Business - Appointment of M/s B S R & Co. LLP, Chartered Accountants (Registration No. 101248W/W-100022) as Statutory Auditors of the Company to fill up the casual vacancy caused due to the resignation of M/s Deloitte Haskins & Sells LLP, Chartered Accountants (Ordinary Resolution). Please find enclosed the results of the postal ballot in the prescribed format along with Scrutinizer's report as 'Annexure 1'. Please note that the resolution has been passed with requisite majority. This is for your information and records. Fortis Healthcare Ltd - 532843 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, February 13, 2019 to, inter-alia, consider and approve the Un-Audited Financial Results for the quarter and period endedDecember 31, 2018. Further, the trading window of the Company for dealing in securities of the Company will remain closed from February 6, 2019 to February 15, 2109 (both days inclusive). This is for your information and record please. FORTIS HEALTHCARE LTD. - 532843 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 039390 Name of the Signatory :- Sumit GoelDesignation :- Company Secretary and Compliance Officer